
    
      Design: Randomized controlled, observer-blind trial comparing sirolimus-eluting stents with
      paclitaxel-eluting stents

      Patients: 1012 patients undergoing percutaneous coronary intervention. The two groups had
      similar baseline clinical and angiographic characteristics.
    
  